Cannabichromene (CBC)

Evidence has suggested that it may play a role in the anti-inflammatory and anti-viral effects of cannabis, and may contribute to the overall analgesic effects of medical cannabis. A study done in March 2010 showed that CBC along with cannabidiol (CBD) and tetrahydrocannabinol (THC) have antidepressant effects. Another study showed that CBC helps promote neurogenesis. But, one of the most promising studies shows that CBC has a great effect on cancer.

Cannabichromene Showing Promise In Treating Cancer

Although cannabichromene isn’t the most popular cannabinoid, research suggests CBC could be very beneficial. According to Halent Labs, a top lab-testing facility, it is believed to inhibit inflammation and pain. In addition, it is believed to stimulate bone growth.

One of the most intriguing findings about cannabichromene is its relationship with cancer. CBC is believed to have anti-proliferative effects, meaning it inhibits the growth of cancerous tumors.

This could be a result of its interaction with anandamide. Anandamide is an endocannabinoid, which means our body produces it naturally. It affects the CB1 receptors, as well as the CB2 receptors, and has been found to fight against human breast cancer. CBC inhibits the uptake of anandamide, which allows it to stay in the bloodstream longer.

Not only does CBC have benefits of its own, but it seems to work with the other cannabinoids to produce a synergistic effect; it gives merit to the saying, “the whole is greater than the sum of its parts.” Even though cannabichromene is found in much smaller concentrations than THC and CBD, its importance should not be overlooked. Never underestimate the power of the entourage effect.

 

LEAVE A REPLY